Health Condition 1: K082- Atrophy of edentulous alveolar ridge Health Condition 2: K081- Complete loss of teeth
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. All cases of complete edentulism, even in resorbed maxilla and mandible. For the mandible, residual ridge crest of at least 4 mm width buccolingually and greater than 8 mm height; for the maxilla, residual ridge crest with enough width to insert a 3.5 mm–diameter implant, and greater than 8 mm height will be included in the study. 2. Immediate and delayed loading cases 3. Patients, in whom grafting procedures or zygomatic implants would be morbid or medical conditions wherein such invasive surgical procedures are contraindicated can undergo TTPHIL-ALL TILT® protocol.
Exclusion criteria
Exclusion criteria: 1. Severely debilitating systemic disease. 2. Patients undergoing chemotherapy and radiotherapy. 3. Restricted mouth opening of the patient such that access of posterior regions of maxillary and mandibular arches are compromised. Evaluation appointments will be performed at 6 months; 1 year; and 2 years for assessing implant survival. The primary outcome measure was implant and prosthesis survival based on function up to 2 years. The secondary outcome measures included marginal bone level evaluation and the incidence of biological and esthetic complications up to 2 years of function.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| An implant will be considered successful (100% survival rate) if fulfilled function of supporting full-arch restoration, stable when tested clinically, no radiolucency on radiographs, and no peri-implant inflammation or suppuration. Therefore, the implant survival rate will be determined based on Malo’s criteria. Prosthetic success: A prosthesis was considered a failure if function was compromised for any reason. Fracture of the implant or any prosthetic component will be recorded, as will be technical complications with the abutments or other prosthetic components up to 2 years of function. Timepoint: 10 days; 2, 4,and 6 months; 1 year; and every 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcome measures included marginal bone level evaluation and soft tissue assessment at 6 months, 1 and 2 years of function. Biological complications: Peri-implantitis, peri-implant mucositis, fistula, bleeding on probing, suppuration, and numbness of the lower lip or chin will be evaluated. Esthetic complications: esthetic complaints of patients Marginal bone level evaluation: CBCT Scans will be performed with standardized scanning parameters at 90 kV, 10 mA, and using a field of view of 11cm × 8 cm.Timepoint: 6 months, 1 and 2 years of function. | — |
Countries
India
Contacts
PhD Guide, Meenakshi Academy of Higher Education and Research